Reefer m/v morjana type, dw 1194 mts on 4, 19 m
New price is usd 600.000, - (keen sellers)
Inspectable at trondheim till 16.02, the unfixed yet.
Ready to consider the delivery in onther region including far east.
Photos, ga, certs : http://en.Album.Ee/inv/jypgzv
Built: 1988, shipyard "baltiya", klaipeda
Flag: russia
Class mrs : km * ice class l3 (1) iaut 2 (l3 at draft < 4, 04 m)
Ss /dd : last - 31.10.2007, next - 03.09.2012
Loa / boa / depth : 85, 10 / 12, 2 / 6, 50 m
2 holds / 2 tweens : ttl capacity 1135 cbm
(holds : 218 and 313 m3, tweens : 263 and 281 m3).
Hatches: 2, 10 x 3, 30 m
Ho dim: 1/ 10x10.5x2.3 m 2/ 12.1 x 10.5 x 2.3 m
Tween dim: 1/ 12 x 10.5 x 2.25 m n. 2/ 13.3 x 10.5 x 2.25 m
Dwcc abt 500 plts of fruit/and vegetable / abt 800 nmt
Of frozen fish in crts herrings min 800 nmt/capelin
Min 850 nmt depend of sf and type of carton) /
Tem. In hold : - 18 deg.
(agent - hladon 12)
Crane : 3, 2 mts swl
Main engine : 8 nvd 48a-2u, 850 kw (1160 hp)
Gmdss : a2
Speed laden 10, 0 kts / consumption about 4, 0 mts go (including
Generators).
(invested ab. Usd 450.000, - to upgrade the vessel in oct. 2007).
Owners' price : usd 0, 6 mio / try delivery in far east
2. General cargo, gearless, dw 2950 on 5, 30 m, built germay 1978.
Timber fitted up to 5000 cbm seasoned sawntimber
Inspection - medet.
Photos / ga / full description - http://en.Album.Ee/inv/4hsrsy
Flag: antigua and barbuda
Built: 1978 / j.J.Sietas schiffswerft germany
Pse advise you need more info about the listed vessels.
We offer from Estonia CNC subcontractor products, we represent also Autodesk Manufactoring in the Baltic States and have very large network machining companys.
5000$ per one unit. Complex Treatment Solution for patients with respiratory insufficiency which can effectively improve blood oxygenation and reduce mortality of patients with 2019-nCoV, is one of the main ways to treat 2019-nCoV.
Respiratory combo solution completely connects a BiPAP and an oxygen concentrator through the integrated structure and data protocol, providing a one-stop solution for patients who needs BiPAP & oxygen treatment, which greatly improve the conveniences, mobility and the effects of treatment.
Therapeutic Product for COVID-19 Patients.
Recommended pertain to adult and paediatric patients with ARDS who are treated with
non-invasive or high-flow oxygen systems.
The BiPAP non-invasive VENTILATOR is suitable for medical institutions and home for cardiopulmonary resuscitation respiratory support.
Acute respiratory failure caused by
various reasons or incomplete oxygenation dysfunction, carbon dioxide retention, post-
operation respiratory support, other respiratory treatment.
Our partners products are officially recognized at the international level,
which is confirmed by the required certification. Ventilators have undergone
all needed testing and we have all test reports required.
At the production stage, ventilator pass
a thorough quality control check at
every stage.
Therapeutic Product for COVID-19 Patients.
Recommended pertain to adult and paediatric patients with ARDS who are treated with
non-invasive or high-flow oxygen systems.
The BiPAP non-invasive VENTILATOR is suitable for medical institutions and home for cardiopulmonary resuscitation respiratory support.
Acute respiratory failure caused by
various reasons or incomplete oxygenation dysfunction, carbon dioxide retention, post-
operation respiratory support, other respiratory treatment.
Our partners products are officially recognized at the international level,, which is confirmed by the required certification. Ventilators have undergone, all needed testing and we have all test reports required., At the production stage, ventilator pass, a thorough quality control check at, every stage.,
Complex Treatment Solution for patients with respiratory insufficiency which can effectively improve blood oxygenation and reduce mortality of patients with 2019-nCoV, is one of the main ways to treat 2019-nCoV.
Therapeutic Product for COVID-19 Patients.
Recommended pertain to adult and paediatric patients with ARDS who are treated with
non-invasive or high-flow oxygen systems.
The BiPAP non-invasive VENTILATOR is suitable for medical institutions and home for cardiopulmonary resuscitation respiratory support.
Acute respiratory failure caused by
various reasons or incomplete oxygenation dysfunction, carbon dioxide retention, post-
operation respiratory support, other respiratory treatment.
Our partners products are officially recognized at the international level,
which is confirmed by the required certification. Ventilators have undergone
all needed testing and we have all test reports required.
At the production stage, ventilator pass
a thorough quality control check at
every stage.
Therapeutic Product for COVID-19 Patients.
Recommended pertain to adult and paediatric patients with ARDS who are treated with
non-invasive or high-flow oxygen systems.
The BiPAP non-invasive VENTILATOR is suitable for medical institutions and home for cardiopulmonary resuscitation respiratory support.
Acute respiratory failure caused by
various reasons or incomplete oxygenation dysfunction, carbon dioxide retention, post-
operation respiratory support, other respiratory treatment.
Our partners products are officially recognized at the international level,
which is confirmed by the required certification. Ventilators have undergone
all needed testing and we have all test reports required.
At the production stage, ventilator pass
a thorough quality control check at
every stage.
Price is 4000$ per unit.
Therapeutic Product for COVID-19 Patients.
TVV-APCV mode recommended pertain to adult and paediatric patients with ARDS who are treated with non-invasive or high-flow oxygen systems.
A BPAP machine is a type of ventilatorâ??a medical device that assists with breathing. These machines extend the benefit of a CPAP machine by adding large breaths on top of stable airway pressure and will help in pushing air into lungs from a mask or nasal cannula connected to the machine.
Complex Treatment Solution for patients with respiratory insufficiency which can effectively improve blood oxygenation and reduce mortality of patients with 2019-nCoV, is one of the main ways to treat 2019-nCoV.
